FDA, COVID-19 and Vaccine
Digest more
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0
The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots. Moderna (MRNA) and Pfizer (PFE) shares move higher on this news, while Novavax (NVAX) takes a dip.
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
A change in recommending Covid vaccines for children and pregnant women would circumvent an expert panel but please many MAHA fans.
Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or eligibility changes this fall.
MSNBC on MSN1d
'It feels like we're just rolling back all vaccine recommendations': Physician on new HHS guidanceThe Wall Street Journal reports HHS is expected to stop recommending routine Covid shots for children and pregnant women. This as new testing requirements could delay the availability of shots. Dr. Kavita Patel joins Ayman Mohyeldin on The 11th Hour.